巴西神经科医师对多发性硬化症患者的诊断和治疗实践评估

数据集获取（Figshare）

• 源站标题：Evaluation of diagnosis and treatment practices of Brazilian neurologists among patients with multiple sclerosis
• DOI：10.6084/m9.figshare.16494244.v1
• 发布日期：2021-08-27
• 文件数：6 个
• 文件总体积：412.45 KB
• 源站页面：https://scielo.figshare.com/articles/dataset/Evaluation_of_diagnosis_and_treatment_practices_of_Brazilian_neurologists_among_patients_with_multiple_sclerosis/16494244

命令行下载

curl -L -o "867bdc9d50ffd77973415a0a3944c6e6ba39299e.jpg" "https://ndownloader.figshare.com/files/30524794"
curl -L -o "9f9b2a52c9eb69fed325db5f56dd9a080fcf1323.jpg" "https://ndownloader.figshare.com/files/30524800"
curl -L -o "Table_1.xls" "https://ndownloader.figshare.com/files/30524803"
curl -L -o "Table_2.xls" "https://ndownloader.figshare.com/files/30524806"
curl -L -o "Table_3.xls" "https://ndownloader.figshare.com/files/30524809"
curl -L -o "Table_4.xls" "https://ndownloader.figshare.com/files/30524815"

文件清单

• 867bdc9d50ffd77973415a0a3944c6e6ba39299e.jpg（375.56 KB）
• 9f9b2a52c9eb69fed325db5f56dd9a080fcf1323.jpg（6.17 KB）
• Table_1.xls（9.73 KB）
• Table_2.xls（5.63 KB）
• Table_3.xls（5.63 KB）
• Table_4.xls（9.73 KB）

文件总体积 412.45 KB（源站 API 实测）。

数据加载示例（图像类）

from PIL import Image
import glob, os

files = (glob.glob(os.path.join(path, "**", "*.png"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.jpg"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.tif"), recursive=True))
print("图像文件数:", len(files))
img = Image.open(files[0]); print("尺寸/模式:", img.size, img.mode)

# torchvision Dataset 方式:
# from torchvision import datasets
# ds = datasets.ImageFolder(path)  # 要求 子目录=类别

目录组织与标注格式以源站说明和下载后实际文件为准。

数据说明

ABSTRACT Background: Recent changes to the diagnostic criteria for multiple sclerosis (MS) and new medications have had a major impact on the way in which specialists manage the disease. Objective: To investigate factors considered by Brazilian neurologists in managing MS, and to identify how these contribute to diagnosis and treatment. Methods: Potential participants were selected by a steering committee (MS experts who developed this survey). Only MS specialists were included in the study (neurologists who had completed a neuroimmunology fellowship or who were treating more than 30 MS patients). Links to the online questionnaire were distributed between March 2019 and January 2020. This questionnaire was composed of sections with hypothetical MS scenarios. Results: Neurologists from 13 Brazilian states responded to the survey (n = 94). In the clinically isolated syndrome (CIS) scenario, the respondents agreed to treat patients with a high risk of MS diagnosis, whereas in the radiologically isolated syndrome (RIS) half of the respondents opted not to treat, even among high-risk patients. In cases of low-activity relapsing-remitting MS (RRMS), the choice of treatment was distributed among interferon beta, glatiramer acetate and teriflunomide, which were changed to fingolimod and natalizumab, as RRMS severity increased. The topics in which disagreement was found included practices regarding use of disease-modifying therapy (DMT) for pregnant patients and the washout period required for some DMTs. Conclusions: This study enabled identification of areas of agreement and disagreement about MS treatment among Brazilian neurologists, which can be used to update future protocols and improve patient management.

许可

CC BY 4.0

引用

学术使用请引用 DOI 10.6084/m9.figshare.16494244.v1（source: https://scielo.figshare.com/articles/dataset/Evaluation_of_diagnosis_and_treatment_practices_of_Brazilian_neurologists_among_patients_with_multiple_sclerosis/16494244）。